| 1. |
王增武. 《中國心血管健康與疾病報告2024》: 心血管疾病及其危險因素流行狀況. 中國心血管病研究, 2025, 23(9): 771-793.Wang ZW. Report on cardiovascular health and diseases in China 2024: epidemiological status of cardiovascular diseases and their risk factors. Chin J Cardiovasc Res, 2025, 23(9): 771-793.
|
| 2. |
Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol, 2020, 76(25): 2982-3021.
|
| 3. |
徐麗, 李秋晨, 付丹麗, 等. 急性心肌梗死與主動脈夾層病人臨床癥狀及體征特點分析. 中西醫結合心腦血管病雜志, 2023, 21(4): 720-723.Xu L, Li QC, Fu DL, et al. Analysis of clinical symptoms and physical signs in patients with acute myocardial infarction and aortic dissection. Chin J Integr Med Cardio-Cerebrovasc Dis, 2023, 21(4): 720-723.
|
| 4. |
Gulati R, Behfar A, Narula J, et al. Acute myocardial infarction in young individuals. Mayo Clin Proc, 2020, 95(1): 136-156.
|
| 5. |
Mir T, Sattar Y, Uddin M, et al. Post-PCI outcomes in STEMI patients with coronary ectasia: meta-analysis. Expert Rev Cardiovasc Ther, 2021, 19(4): 349-356.
|
| 6. |
Bhatt DL, Lopes RD, Harrington RA. Diagnosis and treatment of acute coronary syndromes: a review. JAMA, 2022, 327(7): 662-675.
|
| 7. |
Huang L, Zhang J, Huang Q, et al. In-hospital major adverse cardiovascular events after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a retrospective study under the China chest pain center (standard center) treatment system. BMC Cardiovasc Disord, 2023, 23(1): 198.
|
| 8. |
Ren XY, Li YF, Liu HQ, et al. Anti-inflammatory therapy progress in major adverse cardiac events after PCI: Chinese and western medicine. Chin J Integr Med, 2023, 29(7): 655-664.
|
| 9. |
高緒玲, 楊勝珍, 姚明凱, 等. 急性心肌梗死患者早期惡性室性心律失常的危險因素分析及預測模型構建. 公共衛生與預防醫學, 2025, 36(6): 127-131.Gao XL, Yang SZ, Yao MK, et al. Risk factors and construction of prediction model of early malignant ventricular arrhythmia in patients with acute myocardial infarction. J Public Health Prev Med, 2025, 36(6): 127-131.
|
| 10. |
Moons KG, De Groot JA, Bouwmeester W, et al. Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLoS Med, 2014, 11(10): e1001744.
|
| 11. |
陳香萍, 張奕, 莊一渝, 等. PROBAST: 診斷或預后多因素預測模型研究偏倚風險的評估工具. 中國循證醫學雜志, 2020, 20(6): 737-744.Chen XP, Zhang Y, Zhuang YY, et al. PROBAST: a tool for assessing risk of bias in the study of diagnostic or prognostic multi-factorial predictive models. Chin J Evid-based Med, 2020, 20(6): 737-744.
|
| 12. |
Huang J, Peng X, Fang Z, et al. Risk assessment model for predicting ventricular tachycardia or ventricular fibrillation in ST-segment elevation myocardial infarction patients who received primary percutaneous coronary intervention. Medicine (Baltimore), 2019, 98(4): e14174.
|
| 13. |
鄭曦, 王浩宇, 何莉, 等. 老年冠心病病人PCI術后并發室性心律失常危險因素的探討及風險列線圖模型的建立. 中西醫結合心腦血管病雜志, 2021, 19(6): 973-978.Zheng X, Wang HY, He L, et al. The risk factors of ventricular arrhythmia in elderly patients with coronary heart disease after PCI and establishment of Nomogram risk prediction model. Chin J Integr Med Cardio-Cerebrovasc Dis, 2021, 19(6): 973-978.
|
| 14. |
盧志豪, 劉濤, 王超凡, 等. 急性ST段抬高型心肌梗死直接PCI后新發室性心律失常的危險因素分析. 中國循證心血管醫學雜志, 2022, 14(3): 333-336, 339.Lu ZH, Liu T, Wang CF, et al. Risk factors analysis of new-onset ventricular arrhythmia in patients with acute ST-segment elevation myocardial infarction. Chin J Evid-based Cardiovasc Med, 2022, 14(3): 333-336, 339.
|
| 15. |
Wongthida T, Lumkul L, Patumanond J, et al. Development of a clinical risk score for prediction of life-threatening arrhythmia events in patients with ST elevated acute coronary syndrome after primary percutaneous coronary intervention. Int J Environ Res Public Health, 2022, 19(4): 1997.
|
| 16. |
趙亞妮. 急性ST段抬高型心肌梗死急診PCI術后并發室性心律失常的危險因素分析. 鄭州大學, 2023.Zhao YN. Analysis of related risk factors for ventricular arrhythmia afteremergency PCI in STEMI. Zhengzhou University, 2023.
|
| 17. |
朱守偉, 喻龍姍, 何宗保, 等. 老年急性心肌梗死患者急診PCI術后室性心律失常風險評分標準構建及驗證. 中國急救醫學, 2023, 43(9): 734-740.Zhu SW, Yu LS, He ZB, et al. Construction and verification of the risk scoring criteria for ventricular arrhythmia after emergency PCI in elderly patients with acute myocardial infarction. Chin J Crit Care Med, 2023, 43(9): 734-740.
|
| 18. |
Wang L, Yang L, Li T, et al. Development and validation of nomogram for the prediction of malignant ventricular arrhythmia including circulating inflammatory cells in patients with acute ST-segment elevation myocardial infarction. J Inflamm Res, 2023, 16: 3185-3196.
|
| 19. |
周睿, 彭建軍. STEMI直接PCI術后病人Tp-e/QT比值變化及其對惡性室性心律失常的預測價值. 中西醫結合心腦血管病雜志, 2024, 22(15): 2824-2830.Zhou R, Peng JJ. Changes of Tp-e/QT ratio and its predictive value for malignant ventricular arrhythmia in patients with STEMI after primary PCI. Chin J Integr Med Cardio-Cerebrovasc Dis, 2024, 22(15): 2824-2830.
|
| 20. |
Wang W, Chen M, Guo J, et al. Construction and validation of nomogram model for predicting the risk of ventricular arrhythmia after emergency PCI in patients with acute myocardial infarction. Aging (Albany NY), 2024, 16(9): 8246-8259.
|
| 21. |
王鐸. ST段抬高型急性心肌梗死患者PCI術后再灌注心律失常的風險因素分析. 河南醫學研究, 2025, 34(11): 2035-2038.Wang D. Risk factors analysis of reperfusion arrhythmia in patients with ST-segment elevation acute myocardial infarction after PCI. Henan Med Res, 2025, 34(11): 2035-2038.
|
| 22. |
武曉娟, 倪飛珍, 羅圣棟. 冠心病患者PCI術后發生室性心律失常的預測列線圖構建與評價. 心電與循環, 2025, 44(3): 303-306, 310, 后插2.Wu XJ, Ni FZ, Luo SD. Predictive nomogram construction and evaluation for ventricular arrhythmia occurrence in coronary heart disease patients after percutaneous coronary intervention. Electrocardio Circ, 2025, 44(3): 303-306, 310, Suppl 2.
|
| 23. |
張海洋. 預測急性ST段抬高型心肌梗死患者經皮冠狀動脈介入術后發生心律失常的列線圖模型構建. 內科急危重癥雜志, 2025, 31(3): 165-169.Zhang HY. Construction of nomogram model for predicting arrhythmia after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction. J Intern Intensive Med, 2025, 31(3): 165-169.
|
| 24. |
Iqbal MB. Nonculprit disease in non-ST-segment elevation myocardial infarction and cardiogenic shock. JACC Cardiovasc Interv, 2021, 14(10): 1079-1081.
|
| 25. |
Li X, Ge Z, Kan J, et al. Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial. Lancet, 2024, 403(10439): 1855-1865.
|
| 26. |
伊瑩, 潘慶麗. 冠心病患者經皮冠狀動脈介入術后發生惡性心律失常的影響因素. 河南醫學研究, 2022, 31(9): 1626-1629.Yi Y, Pan QL. Influencing factors of malignant arrhythmia after percutaneous coronary intervention in patients with coronary heart disease. Henan Med Res, 2022, 31(9): 1626-1629.
|
| 27. |
王藝璇, 宋瓊, 顏琬華. 衰弱評估聯合Killip分級對急性心梗患者PCI術后并發癥的預測研究. 中國老年保健醫學, 2021, 19(1): 23-26.Wang YX, Song Q, Yan WH. Study on the prediction of the combination of frailty assessment and Killip grade on PCI postoperative complications in acute myocardial infarction patients. Chin J Geriatr Care, 2021, 19(1): 23-26.
|
| 28. |
Kim M, Kim J, Lee JH, et al. Impact of improved left ventricular systolic function on the recurrence of ventricular arrhythmia in heart failure patients with an implantable cardioverter-defibrillator. J Cardiovasc Electrophysiol, 2016, 27(10): 1191-1198.
|
| 29. |
Murphy SA, Dauterman K, De Lemos JA, et al. Angiographic and clinical characteristics associated with the development of Q-wave and non-Q-wave myocardial infarction in the thrombolysis in myocardial infarction (TIMI) 14 trial. Am Heart J, 2003, 146(1): 42-47.
|
| 30. |
Puljevic D, Smalcelj A, Durakovic Z, et al. Effects of postmyocardial infarction scar size, cardiac function, and severity of coronary artery disease on QT interval dispersion as a risk factor for complex ventricular arrhythmia. Pacing Clin Electrophysiol, 1998, 21(8): 1508-1516.
|
| 31. |
閆迎川, 張鳳祥, 李小榮, 等. 急性心肌梗死患者血糖水平與惡性室性心律失常發生的相關性. 中國心臟起搏與心電生理雜志, 2011, 25(3): 230-233.Yan YC, Zhang FX, Li XR, et al. The correlation between blood glucose level and the incidence of malignant ventricular arrhythmias in patients with acute myocardial infarction. Chin J Cardiac Pacing Electrophysiol, 2011, 25(3): 230-233.
|
| 32. |
Sourour N, Riveland E, N?sgard P, et al. Associations between biomarkers of myocardial injury and systemic inflammation and risk of incident ventricular arrhythmia. JACC Clin Electrophysiol, 2024, 10(9): 2021-2032.
|
| 33. |
Wu CI, Chang SL, Lin CY, et al. Clinical significance of J wave in prediction of ventricular arrhythmia in patients with acute myocardial infarction. J Cardiol, 2019, 73(5): 351-357.
|
| 34. |
J?ns C, Zheng C, Winsl?w UCG, et al. Increasing the potassium level in patients at high risk for ventricular arrhythmias. N Engl J Med, 2025, 393(20): 1979-1989.
|
| 35. |
奚麗婧, 郭昭艷, 楊雪珂, 等. LASSO及其拓展方法在回歸分析變量篩選中的應用. 中華預防醫學雜志, 2023, 57(1): 107-111.Xi LJ, Guo ZY, Yang XK, et al. Application of LASSO and its extended method in variable selection of regression analysis. Chin J Prev Med, 2023, 57(1): 107-111.
|
| 36. |
Nattino G, Pennell ML, Lemeshow S. Assessing the goodness of fit of logistic regression models in large samples: a modification of the Hosmer-Lemeshow test. Biometrics, 2020, 76(2): 549-560.
|
| 37. |
陳瀅伊, 尹遇冬. 比索洛爾在冠脈支架術后心律失常及心電圖QT間期延長預防中的作用. 黑龍江醫藥科學, 2025, 48(6): 126-128.Chen YY, Yin YD. Effect of bisoprolol in prevention of arrhythmia and prolonged QT interval on electrocardiogram after coronary stenting. Heilongjiang Med Pharm, 2025, 48(6): 126-128.
|
| 38. |
Collins GS, Reitsma JB, Altman DG, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Circulation, 2015, 131(2): 211-219.
|
| 39. |
Fitzpatrick R, Stefan MI. Validation through collaboration: encouraging team efforts to ensure internal and external validity of computational models of biochemical pathways. Neuroinformatics, 2022, 20(1): 277-284.
|
| 40. |
王亞琪. 基于IPD與AgD結合的網狀Meta回歸模型研究. 蘭州大學, 2023.Wang YQ. A study of combining IPD and AgD in networkmeta regression. Lanzhou University, 2023.
|